1. Home
  2. NXTC vs STFS Comparison

NXTC vs STFS Comparison

Compare NXTC & STFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXTC
  • STFS
  • Stock Information
  • Founded
  • NXTC 2015
  • STFS 2015
  • Country
  • NXTC United States
  • STFS China
  • Employees
  • NXTC N/A
  • STFS N/A
  • Industry
  • NXTC Biotechnology: Pharmaceutical Preparations
  • STFS
  • Sector
  • NXTC Health Care
  • STFS
  • Exchange
  • NXTC Nasdaq
  • STFS NYSE
  • Market Cap
  • NXTC 13.9M
  • STFS 16.2M
  • IPO Year
  • NXTC 2019
  • STFS 2024
  • Fundamental
  • Price
  • NXTC $0.48
  • STFS $1.03
  • Analyst Decision
  • NXTC Strong Buy
  • STFS
  • Analyst Count
  • NXTC 2
  • STFS 0
  • Target Price
  • NXTC $3.50
  • STFS N/A
  • AVG Volume (30 Days)
  • NXTC 336.1K
  • STFS 370.9K
  • Earning Date
  • NXTC 07-31-2025
  • STFS 02-14-2025
  • Dividend Yield
  • NXTC N/A
  • STFS N/A
  • EPS Growth
  • NXTC N/A
  • STFS N/A
  • EPS
  • NXTC N/A
  • STFS 0.01
  • Revenue
  • NXTC N/A
  • STFS $16,754,197.00
  • Revenue This Year
  • NXTC N/A
  • STFS N/A
  • Revenue Next Year
  • NXTC N/A
  • STFS N/A
  • P/E Ratio
  • NXTC N/A
  • STFS $108.79
  • Revenue Growth
  • NXTC N/A
  • STFS 75.86
  • 52 Week Low
  • NXTC $0.22
  • STFS $0.80
  • 52 Week High
  • NXTC $1.82
  • STFS $17.91
  • Technical
  • Relative Strength Index (RSI)
  • NXTC 44.82
  • STFS N/A
  • Support Level
  • NXTC $0.45
  • STFS N/A
  • Resistance Level
  • NXTC $0.51
  • STFS N/A
  • Average True Range (ATR)
  • NXTC 0.07
  • STFS 0.00
  • MACD
  • NXTC -0.01
  • STFS 0.00
  • Stochastic Oscillator
  • NXTC 3.24
  • STFS 0.00

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

About STFS STAR FASHION CULTURE HOLDINGS LIMITED

Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.

Share on Social Networks: